Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Apr 25, 2022 7:00 AM - Apr 27, 2022 12:00 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

DIA/FDA Oligonucleotide-Based Therapeutics Conference

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Highlights & Features

What is happening at Oligonucleotide-Based Therapeutics Conference

  • Track 1: Clinical

  • There are more than a dozen oligonucleotide based products approved for therapeutic use and nearly 100 currently in clinical testing. Track 1 will explore the lessons learned and the ongoing challenges to clinical use of oligos. The Track sessions are divided by tissue, including kidney, brain, eye, liver and other extrahepatic. Another session will cover Clinical Pharmacology and a special concurrent session will cover Individualized ASO Products.

  • Track 2: Non Clinical

  • The nonclinical track will focus on development and safety assessments of oligonucleotide-based therapeutics. A variety of modalities, routes of administration, and methodologies will be discussed.

  • Track 3: CMC

  • This track provides an interactive forum for innovators and regulators to present and discuss cutting edge topics in oligonucleotide chemistry, manufacturing, and controls (CMC). The track emphasizes topics that are emerging (e.g., use of platform knowledge, ICH Q14, new oligonucleotide modalities) and will require ongoing collaboration with global regulators. Attendees will take away a deeper understanding of key developments, along with insight into current challenges and successful strategies for navigating this complex area.

Upon completion of the live registration, participants will gain access to the following:

  • Live Event Access
  • Presentation Slides

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.